Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao, Quan Yuan, Haiyan Wang, +22

Clinical Infectious Diseases

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young‐Jun Park, Martina Beltramello, +22

Nature

Vaccine TargetImmunologyAntibody EngineeringMedicineCovid-19

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu, Pengfei Wang, Manoj S. Nair, +21

Nature

VaccinationVaccine TargetMultiple EpitopesImmunologyAntibody Engineering +3

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang, Fabian Schmidt, Yiska Weisblum, +31

Nature

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers, Fangzhu Zhao, Deli Huang, +31

Science

VaccinationVaccine DevelopmentNon-rbd EpitopesEmerging Infectious DiseasesVaccine Target +13

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow, Carl Graham, Blair Merrick, +38

Nature Microbiology

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg, Fatima Amanat, Adolfo Firpo, +15

Science

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz, Verity Hill, John T. McCrone, +21

Cell

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie, Qianqian Li, Jiajing Wu, +15

Emerging Microbes & Infections

VaccinationDiagnostic VirologyViral DiagnosticsPseudovirus-based Neutralization AssayPseudovirus Neutralization Assay +11

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

Amin Addetia, Katharine H. D. Crawford, Adam S. Dingens, +6

Journal of Clinical Microbiology